
FDA Approves Groundbreaking Pill to Lower Cholesterol in High Risk Patients
The U.S. Food and Drug Administration on Thursday approved Lipfendra, the first once-daily pill designed to lower cholesterol through a mechanism that previously required injections, offering a potentially transformative option for millions of Americans with dangerously high cholesterol levels that…















